ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1029

Cytomegalovirus Enteritis in a Kidney Transplant Recipient with Minimal Viremia

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical

Authors

  • Perlmutter, Jason Jessie, Albany Medical College, Albany, New York, United States
  • Lightle, Andrea R., Albany Medical College, Albany, New York, United States
  • Shahbazov, Rauf, Albany Medical College, Albany, New York, United States
  • Faddoul, Giovanni, Albany Medical College, Albany, New York, United States
Introduction

Cytomegalovirus (CMV) is a frequent complication of transplant recipients, and therapy is warranted in cases of isolated viremia and organ infection. CMV Viral Load (VL) is sensitive for diagnosis and monitoring of treatment. The case discusses a patient with severe CMV enteritis that resulted in small bowel obstruction (SBO) with minimal VL.

Case Description

46M w/ESKD due to FSGS s/p DDKT (CMV – to +) 5 years ago, thymoglobulin induced. On tacrolimus, mycophenolate, belatacept. 2 years post-transplant, he had CMV viremia treated with valganciclovir. He presented 2 years later w/ abdominal pain + decreased appetite. CMV viremia confirmed with VL of 36.9IU/mL and was untreated due to the low VL. For the next two months, he was admitted and discharged 3x with conservative treatment of SBO. EGD noted impassible jejunal stricture w/ ulceration + for CMV immunohistochemical stain and EBER in situ negative. VL < 34.5. He was treated w/ IV Ganciclovir and transitioned to PO valganciclovir. He was readmitted with SBO, severe weight loss, and had a small bowel resection w/ anastomosis, mesenteric lymph node excision, and discharged once tolerating PO.

Discussion

This patient had a low VL with biopsy proven CMV enteritis. American guidelines agree there is a lack of a widely applicable VL threshold for diagnosis and pre-emptive therapy. Antiviral therapy is recommended for asymptomatic viremia. A low VL does not rule out localized GI CMV disease.

Digital Object Identifier (DOI)